Merchavia Holdings and Investments Ltd, formerly NEPCO STAR LTD, is an Israel-based company. The Company sold its jewelry business in 2007 and rents out a commercial development that was developed by NEPCO STAR LTD. in 1993.

Employees

Sector

Biotechnology & Medical Research

More about the company

Capitalization	37.07M 12.3M 10.42M 9.6M 9.06M 16.92M 1.14B 17.23M 113M 44.17M 550M 46.14M 45.17M 1.95B	P/E ratio 2024	-1.43x	P/E ratio 2025	-4.31x
Enterprise value	37.46M 12.43M 10.53M 9.7M 9.16M 17.1M 1.16B 17.41M 114M 44.65M 556M 46.64M 45.65M 1.97B	EV / Sales 2024	76.2x	EV / Sales 2025	110x
Free-Float	22.31%	Yield 2024 *	-	Yield 2025	-

Mar. 31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Dec. 10	E.F.A. Engineering For All Ltd announced that it expects to receive $2 million in funding from Merchavia Holdings and Investments Ltd	CI
25-08-31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-06-28	CardiacSense Ltd. announced that it expects to receive $5 million in funding from Merchavia Holdings and Investments Ltd	CI
25-03-31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-08-29	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-03-31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-03-05	E.F.A. Engineering For All Ltd announced that it has received $3 million in funding from Merchavia Holdings and Investments Ltd	CI
23-08-31	Merchavia Holdings and Investments Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	CI
17-06-03	CardiacSense Ltd. announced that it has received $1 million in funding from Merchavia Holdings and Investments Ltd. and another investor	CI
17-03-22	CardiacSense Ltd. announced that it expects to receive $1 million in funding from Merchavia Holdings and Investments Ltd. and another investor	CI
16-11-15	Cleveland Diagnostics, Inc. announced that it expects to receive funding from Merchavia Holdings and Investments Ltd.	CI
16-09-04	Juventas Therapeutics, Inc. announced that it expects to receive $10 million in funding from Merchavia Holdings and Investments Ltd. and other investors	CI

19-03-20	Merchavia Expands Its Investments in Diagnostics: The Company to Invest NIS 1 Million in EFA - Engineering for All Ltd.	PR
18-11-26	Merchavia and Investments : Signs MoU for First Investment in the Medical Cannabis Sector	PR

Manager	Title	Age	Since
Eli Arad CEO	Chief Executive Officer	53	2010-12-08
Ilan Goldstein PSD	President	65	2021-11-18
Eran Schenker CTO	Chief Tech/Sci/R&D Officer	63	2021-01-03

Director	Title	Age	Since
Rani Lifshitz CHM	Chairman	59	2014-05-26
Michal Aharon BRD	Director/Board Member	51	2014-05-10
Ophir Shahaf BRD	Director/Board Member	59	2019-03-13

Merchavia Holdings and Investments Ltd Stock TEL AVIV STOCK EXCHANGE

Equities

MRHL

IL0002570146

Biotechnology & Medical Research

Valuation: Merchavia Holdings and Investments Ltd

Latest news: Merchavia Holdings and Investments Ltd

Press Releases: Merchavia Holdings and Investments Ltd

Quotes and Performance

Managers and Directors: Merchavia Holdings and Investments Ltd

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
MERCHAVIA HOLDINGS AND INVESTMENTS LTD	+3.81%	+23.74%	-	-	12.14M
LONZA GROUP AG	+2.32%	+5.17%	-0.53%	-9.85%	45.84B
BEONE MEDICINES AG	+1.96%	+2.74%	+28.59%	+18.24%	33.9B
IQVIA HOLDINGS INC.	+1.84%	+2.57%	+15.96%	-12.65%	28.87B
CELLTRION, INC.	+2.00%	+1.69%	+28.53%	+20.92%	27.52B
REVOLUTION MEDICINES, INC.	+5.87%	+49.88%	+295.72%	+551.85%	27.01B
REGENCELL BIOSCIENCE HOLDINGS LIMITED	-4.00%	+11.81%	+3,526.73%	+4,127.74%	15.94B
ASCENDIS PHARMA A/S	-0.42%	+12.37%	+59.33%	+205.24%	15.36B
MEDPACE HOLDINGS, INC.	+2.80%	+1.24%	+68.63%	+167.93%	14.31B
EUROFINS SCIENTIFIC SE	+5.52%	+5.29%	+37.68%	+10.42%	13.37B
Average	+2.32%	+5.81%	+451.18%	+564.43%	24.68B
Weighted average by Cap.	+2.28%	+5.83%	+309.75%	+390.71%

	2024	2025
Net sales	119K 39.48K 33.46K 30.82K 29.09K 54.32K 3.68M 55.3K 362K 142K 1.77M 148K 145K 6.27M	415K 138K 117K 107K 101K 189K 12.82M 193K 1.26M 495K 6.16M 517K 506K 21.86M
Net income	-6.97M -2.31M -1.96M -1.81M -1.7M -3.18M -215M -3.24M -21.23M -8.31M -103M -8.68M -8.5M -367M	-10.16M -3.37M -2.86M -2.63M -2.48M -4.64M -314M -4.72M -30.94M -12.11M -151M -12.65M -12.38M -535M
Net Debt	-1.38M -458K -389K -358K -338K -631K -42.68M -642K -4.21M -1.65M -20.5M -1.72M -1.68M -72.81M	399K 132K 112K 103K 97.54K 182K 12.32M 185K 1.22M 475K 5.92M 497K 486K 21.02M